Mesothelioma Related Clinical Trials:
A Randomized Study to Assess Whether Radiotherapy Prevents Skin Lumps at Sites Where Needles or Tubes Have Been Inserted in Patients With Malignant Mesothelioma

Article Tools:

In Page Navigation: - General Info - Purpose - Eligibility - Contacts & Locations - Additional Information

   

Status: Active
Sponsors and Collaborators: University of Glasgow
Information provided by: National Cancer Institute (NCI)
Government Identifier: NCT00006231

Condition: Malignant Mesothelioma; Perioperative/Postoperative Complications; Quality of Life
Intervention: Procedure: management of therapy complications; Procedure: quality-of-life assessment; Procedure: radiation therapy

    - Return To Top

Purpose:


RATIONALE: Radiation therapy uses high-energy x-rays to damage tumor cells. It is not yet known if radiation therapy is effective in preventing metastatic cancer following surgery.

PURPOSE: Randomized phase III trial to determine the effectiveness of radiation therapy in preventing metastatic cancer in patients who have undergone diagnostic procedures to identify malignant mesothelioma.

Study Type:   Interventional
Study Design:   Treatment
Official Title:   A Randomized Study to Assess Whether Radiotherapy Prevents Skin Lumps at Sites Where Needles or Tubes Have Been Inserted in Patients With Malignant Mesothelioma

Further study details as provided by National Cancer Institute (NCI):

Primary Outcome Measures:
  • Incidence of metastatic skin nodules [ Designated as safety issue: No ]

Estimated Enrollment:   44
Study Start Date:   February 1998

Detailed Description:

OBJECTIVES:

  • Determine the efficacy of radiotherapy in the prevention of metastatic skin nodules or tumor seeding following invasive diagnostic procedures, such as chest drain insertion, pleural aspiration, pleural biopsy, and thoracoscopy, in patients with malignant mesothelioma.
  • Determine whether the nodules that develop after radiotherapy are symptomatic in these patients.
  • Compare the quality of life of patients treated with radiotherapy vs standard care alone.

OUTLINE: This is a randomized study.

Patients are randomized to 1 of 2 treatment arms.

  • Arm I: Patients receive radiotherapy on 3 consecutive days beginning within 3 weeks after chest drain insertion, pleural aspiration, pleural biopsy, or thoracoscopy and once the wounds have healed.
  • Arm II: Patients receive standard supportive care alone. Quality of life is assessed at baseline, and then at 1, 2, 4, 6, 9, and 12 months.

Patients are followed at 1, 2, 4, 6, 9, and 12 months.

PROJECTED ACCRUAL: A total of 44 patients (22 per arm) will be accrued for this study within 2 years.

    - Return To Top

Eligibility:

Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No

Criteria

DISEASE CHARACTERISTICS:

  • Histologically proven malignant pleural mesothelioma by chest drain insertion, pleural aspiration, pleural biopsy, and/or thoracoscopy within the past 3 weeks

PATIENT CHARACTERISTICS:

Age:

  • Not specified

Performance status:

  • Not specified

Life expectancy:

  • At least 3 months

Hematopoietic:

  • Not specified

Hepatic:

  • Not specified

Renal:

  • Not specified

PRIOR CONCURRENT THERAPY:

Biologic therapy:

  • Not specified

Chemotherapy:

  • No prior systemic chemotherapy for malignant mesothelioma

Endocrine therapy:

  • Not specified

Radiotherapy:

  • No prior local radiotherapy for malignant mesothelioma

Surgery:

  • See Disease Characteristics
  • No other invasive procedures to the same chest site during and for 1 year after study

    - Return To Top

Contacts and Locations:

Please refer to this study by its ClinicalTrials.gov identifier: NCT00006231
Locations
United Kingdom, Scotland
Gartnavel General Hospitall    
      Glasgow, Scotland, United Kingdom, G12 0YN
Stobhill General Hospital    
      Glasgow, Scotland, United Kingdom, G21 3UW
West of Scotland Cancer Centre    
      Glasgow, Scotland, United Kingdom, G11 6NT

Sponsors and Collaborators
University of Glasgow

Investigators
Study Chair:     Noelle O'Rourke, MD     University of Glasgow    

    - Return To Top

Additional Information:

Publications of Results:
O'Rourke N, Paul J, Hill J: Radiotherapy to mesothelioma drain sites may not be worthwhile: interim report of a randomized study. Lung Cancer 29(1 Suppl 1): A-568, 168, 2000.

Study ID Numbers:   CDR0000068155, CRC-BOC-L52, EU-20033
First Received:   September 11, 2000
Last Updated:   January 12, 2008
ClinicalTrials.gov Identifier:   NCT00006231
Health Authority:   United States: Federal Government

Keywords provided by National Cancer Institute (NCI):
localized malignant mesothelioma  
advanced malignant mesothelioma  
perioperative/postoperative complications  
quality of life  

Study placed in the following topic categories:
Signs and Symptoms
Pathologic Processes
Postoperative Complications
Neoplasm Metastasis
Quality of Life
Mesothelioma
Adenoma
Neoplasms, Glandular and Epithelial

Additional relevant MeSH terms:
Neoplasms
Neoplasms by Histologic Type
Mesothelioma
Neoplasms, Mesothelial
Pathological Conditions, Signs and Symptoms

    - Return To Top

Free case consultation

If you or a loved one has been diagnosed with mesothelioma or another asbestos-related disease, contact us using the form below to speak with a mesothelioma consultant, free of charge.